(Z)-tert-butyl 2-(5-(4-ethoxybenzylidene)-2,4-dioxothiazolidin-3-yl)acetate → (Z)-2-(5-(4-ethoxybenzylidene)-2,4-dioxothiazolidin-3-yl)acetic acid
Reaction equation
[CH2:1]([O:3][C:4]1[CH:25]=[CH:24][C:7](/[CH:8]=[C:9]2/[C:10](=[O:23])[N:11]([CH2:15][C:16]([O:18]C(C)(C)C)=[O:17])[C:12](=[O:14])[S:13]/2)=[CH:6][CH:5]=1)[CH3:2].NCCN1C(=O)C(CC2C=CC(OCC)=CC=2)SC1=O>>[CH2:1]([O:3][C:4]1[CH:25]=[CH:24][C:7](/[CH:8]=[C:9]2/[C:10](=[O:23])[N:11]([CH2:15][C:16]([OH:18])=[O:17])[C:12](=[O:14])[S:13]/2)=[CH:6][CH:5]=1)[CH3:2]Participants
3
Procedure
The title compound 28h was prepared by deprotection of tert-butyl group of compound 28g (300 mg, 0.82 mmol). Deprotection following the procedure of compound 6 gave the title compound 28h as a yellow solid (93.4%, 235 mg).
Sources & evidence
- ORD record
- ord-9b65d6db43ce4f728fc7a325a431f427